Shirin Sabouri1, Silvia Chang2,3, Richard Savdie4, Jing Zhang5, Edward Jones6, Larry Goldenberg4,7, and Piotr Kozlowski2,4,5,7
1Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada, 2Radiology, University of British Columbia, Vancouver, BC, Canada, 3Vancouver General Hospital, Vancouver, BC, Canada, 4Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, 5UBC MRI Research Center, Vancouver, BC, Canada, 6Pathology, Vancouver General Hospital, Vancouver, BC, Canada, 7Vancouver Prostate Centre, Vancouver, BC, Canada
Synopsis
MR
multi-exponential T2 mapping
can be used for extracting valuable information about tissue composition in
prostate. Using this technique, the fractional volume of the luminal space in
the prostatic tissue can be determined. Since tissue composition and the amounts
of lumen differ between normal and cancerous tissues, this technique can be applied
for detection of prostatic tumors. We have investigated the
suitability of using MR
multi-exponential T2 mapping for detection and staging
of prostate cancer. We have acquired and analyzed MR images of 11 patients, and
concluded that this technique is highly sensitive and specific in detection of
prostatic tumors.Target Audience
Clinicians and researchers interested in detection
and staging of prostate cancer.
Purpose
To introduce an MRI
technique for detection and grading of prostate tumors, and characterization of
prostatic tissue.
Introduction
MR multi-exponential T
2 mapping is a
well-known imaging technique that has been applied for tracking histo-pathological
changes in organs such as brain
1. Evidence of multi-exponential T
2
decay from prostatic tissue has been presented before
2, but the
suitability of this technique for diagnosis of prostate cancer has not been
studied in details. Using multi-exponential
T
2 mapping, the fractional volume of the luminal space, or so called
luminal water fraction (LWF), in the prostatic tissue can be determined. Because of the
difference of tissue composition and lumen percentage in normal and cancerous
prostatic tissues, we hypothesized that MR multi-exponential T
2 mapping
can be used for the detection and staging of prostate cancer. We have acquired
and analyzed MR images of 11 patients, and investigated the accuracy of this
technique in detection and evaluation of prostatic tumors by performing
multi-parametric statistical analysis.
Methods
Data acquisition was
carried out at the University of British Columbia (UBC) MRI Research Centre,
using a 3.0T whole body MR
scanner [Achieva 3.0T, Philips Medical Systems, Best, The Netherlands]. Eleven patients with biopsy proven cancer underwent MRI scan with an endorectal
coil, prior to undergoing prostatectomy. A 3D multi-echo spin echo sequence (TR/TE=3061/25ms, NE=64, FOV=240x240x40mm
3,
voxel-size=1x1x4mm
3, matrix-size=240x240) was used for scanning of
the entire prostate gland. Images were analyzed with Matlab [The MathWorks Inc,Natick,
MA, USA]. The analysis involved regularized Non-Negative Least Squares (NNLS)
3,4
fitting of multi-exponential decay curves, which generated T
2
distributions for every pixel (see Figure 1). The following parameters were
defined and used to describe the T
2 distributions: number of
distinguishable T
2 components (N) determined by counting the number
of peaks in the distribution; geometric mean of the short (T
2-short)
and long (T
2-long) components, as well as the geometric mean of the
entire distribution (gmT
2); ratio of area under the long component over
the total area under the entire distribution (Luminal Water Fraction – LWF);
and areas under the short (A
1) and long (A
2) components. Average values of these parameters were
calculated within 255 ROIs manually outlined on digitized images of the
whole-mount histology sections registered to MRI images
5. Selection
of ROIs included: cancerous peripheral (PZ) and transition (TZ) zones, and normal
PZ, TZ, Anterior Fibromuscular Stroma (AFMS), and Periurethral Fibromuscular
stroma (PFMS). Statistical analyses were performed with MedCalc [MedCalc
Software, Mariakerke, Belgium]. Significant differences between MR parameters of tumor and normal tissues
were determined with Kruskal-Wallis test. Correlations between MR
parameters and Gleason score were evaluated in PZ and TZ with Spearman’s rank
correlation test. Sensitivity and specificity were calculated by Receiver Operating Characteristic (ROC) analysis of individual
and combined MR parameters.
Results and Discussions
Representative MR parametric maps are shown in
Figure 2. Kruskal-Wallis test indicated
that the average values of T
2-short, gmT
2,
A
1, A
2, and LWF were significantly
different between tumor and normal tissue in PZ and TZ, suggesting that these five parameters can be used as tumor
indicator in prostate. The average values of
N were significantly different between the glandular tissue (i.e.
PZ and TZ) and non-glandular tissue (i.e. AFMS and PFMS); hence, N can be used for tissue classification and
machine learning purposes. The highest correlation with Gleason score was
obtained for LWF (-0.734, p <0.001 in PZ, and -0.712, p <0.001 in TZ).
The values of sensitivity, specificity, and Area Under the ROC Curve (AUC) demonstrated
high accuracy of tumour detection with the proposed technique (Table 1).
The results of this pilot study demonstrate the
suitability of MR multi-exponential T
2 mapping for prostate cancer
diagnosis. Several parameters were defined to characterize T
2 decay
curve of prostatic tissue, and it was shown that the defined parameters were
successfully applied for prostate tissue classification, detection of its cancerous tissue with high sensitivity and specificity, and grading of prostate
cancer.
Acknowledgements
This study has been
supported by the Canadian Institutes of Health Research. We thank Margaret Luk,
Laura Barlow, and Alex Mazur for their kind support and assistance in this
research.References
[1] MacKay
A, et al. Magn Reson Med 1994;31:673–677. [2] Storås T. H., et al. J. Magn. Reson. Imaging.
2008;28:1166–1172. [3]
Bjarnason TA., Mitchell JR. J Magn
Reson 2010;206:200–4. [4] Prasloski T., et al. Magn Reson Med.
2012;67(6):1803-14. [5] Uribe CF et al., Magn. Reson. Imaging, 2015;33:577-583.